RecruitingPhase 4NCT03105843

Sensory-Mechanical Responses to Eucapneic Voluntary Hyperventilation and Mannitol

Sensory-Mechanical Responses to Eucapneic Voluntary Hyperventilation and Mannitol in Individuals With Cough Variant Asthma and Chronic Cough


Sponsor

Dr. Diane Lougheed

Enrollment

30 participants

Start Date

Mar 1, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The objectives of this study are to determine the sensory-mechanical responses to Eucapneic Voluntary Hyperventilation (EVH) and Mannitol in individuals with cough variant asthma (CVA) and methacholine-induced cough with normal airway sensitivity (COUGH) and compare these responses to a control group of healthy individuals without asthma or chronic cough. We hypothesize: 1. EVH and Mannitol cause dyspnea, cough, small airway obstruction with resultant dynamic hyperinflation, gas trapping and autoPEEP in individuals with CVA and COUGH, but not healthy controls. 2. The sensory-mechanical responses to both hyperosmolar challenges (EVH and Mannitol) are comparable within groups (CVA, COUGH and healthy controls).


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study is looking at how the airways respond to two different breathing challenges — one involving fast breathing (hyperventilation) and one involving inhaling a powder called mannitol — in people with a condition called cough variant asthma (CVA) and in healthy people. The goal is to better understand what triggers coughing and airway sensitivity. **You may be eligible if...** - You are between 18 and 65 years old - You have been diagnosed with cough variant asthma (CVA): you have had a chronic cough for 8+ weeks as your main symptom, your airways showed sensitivity to a methacholine test, and your cough improved with asthma medications - OR you have a chronic cough for 8+ weeks but a normal methacholine test result - OR you are a healthy person with no history of asthma or chronic cough **You may NOT be eligible if...** - Your condition worsened in the last 4 weeks, requiring a change in medication, an ER visit, or hospitalization - You are unable to perform acceptable breathing (spirometry) tests - You have a medical reason why you cannot do a methacholine challenge test - You have smoked heavily (more than 10 pack-years) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGMethacholine (MCh) Challenge Testing

Visit 1: Informed consent, Baseline screening and pulmonary function tests and Low-dose methacholine challenge testing using partial and full flow-volume loops.

DIAGNOSTIC_TESTEucapneic Voluntary Hyperventilation (EVH)

Visit 2 or 3: Will be conducted in random order and subjects will perform one of the two challenge tests at either visit.

DRUGMannitol Inhalation Kit

Visit 2 or 3: Will be conducted in random order and subjects will perform one of the two challenge tests at either visit.


Locations(1)

Kingston Health Sciences Centre

Kingston, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03105843


Related Trials